Browse drugs

… during treatment with PD-1 inhibitors. Eight patients received pembrolizumab (six as monotherapy and two in combination with carboplatin plu…

…ed so was discontinued.Other medications tried were colchicine, hydroxychloroquine, IV-Ig, and cyclosporine, tocilizumab and abatacept with subopt…

…steroids in children and highlighted safe use of agents such as baricitinib. Platform trials of the hyperinflammatory syndrome (paediatric …

…Objective Methylprednisolone pulses (MP) help achieve prolonged remission in patients with m…

…is is a rarely reported yet potentially fatal adverse effect of apixaban. This case involves a patient in her 60s who presented with lef…

…mplications.Conclusion and Relevance In this real-world cohort, axi-cel showed predictable but significant toxicity, including universa…

…s In 06/2025, the patient began treatment with tremelimumab and durvalumab. Three weeks after the first cycle he developped cough and desa…

… a tapering regimen at 1 mg/Kg/day), tocilizumab (8 mg/kg), and anakinra (200 mg/day). The clinical pharmacist followed the patient thro…

…olone 2 mg/kg for at least 72 hours and underwent liver biopsy. Ursodeoxycholic acid was added in mixed and cholestatic drug-induced liver injury (D…

…Objectives Methylprednisolone (mPSL) pulse therapy is an essential treatment for systemic lup…

…anti-Sm, and anticardiolipin antibodies. After a flare in 2016, mycophenolate mofetil (MMF) was started, leading to remission. From 2018, she suffere…

…vity, Lupus nephritis. She was treated with Methylprednisolone, Hydroxychloroquine, Azathioprine, one infusion of Belimumab. After 18 month evolut…